• Cardiva Medical (Mountain View, California) reported the addition of two officers to the management team. Malcolm Farnsworth joins Cardiva as VP of finance and CFO. Tara Zerby joins Cardiva as VP of business development and marketing. Previously, Farnsworth was executive VP and CFO at Point Biomedical. Zerby was formerly VP and general manager of RTI-Cardiovascular. Cardiva is a private company focused on developing vascular access site management and closure devices.

• CSMG Technologies (Corpus Christi, Texas) reported that its subsidiary, Live Tissue Connect, has named Frank D’Amelio president and named him to the board. Previously, D’Amelio was CTO for Gyrus Group. CSMG is a technology management company.

• Intrepid Holdings (Houston) reported the appointment of Eddie Austin, Jr. as acting CEO and chairman of its board. Austin previously managed a law practice in Lake Charles, Louisiana, from 1990 until 2006. Intrepid is a provider of clinic, pharmacy, and related healthcare services to the urban marketplace.

• Outcome Sciences (Cambridge, Massachusetts) has named Francis Campion, MD, as medical director of provider programs, to work with hospitals and physician professional societies to deliver clinical outcomes programs to improve clinical quality and patient safety. Campion is the director for the complex chronic care disease management program at Harvard Vanguard Medical Associates. Outcome Sciences makes clinical patient registries and quality improvement initiatives for evaluating and improving real-world outcomes.

• David Burkhardt, MD, has been named chief medical officer of Stereotaxis (St. Louis). Burkhardt was most recently associate program director for the clinical cardiac electrophysiology fellowship training program at the Lerner Case Western Reserve School of Medicine at the Cleveland Clinic. Stereotaxis makes a cardiology instrument control system for use in the surgical suite.